Wortmannin inhibits proliferation and induces apoptosis of MCF-7 breast cancer cells

European Journal of Gynaecological Oncology

Volumn 33, Issue 4, 2012, Pages 367-369

  Yun, J ^a   Lv, Y G ^a   Yao, Q ^a   Wang, L ^a   Li, Y P ^a   Yi, J ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; MCF 7 cell line; PI3K Akt; Proliferation; Wortmannin

Indexed keywords

DIMETHYL SULFOXIDE; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEIN KINASE B; WORTMANNIN;

APOPTOSIS; ARTICLE; ASSAY; BREAST CANCER; CELL COUNT; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INHIBITION KINETICS; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANDROSTADIENES; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84866113885     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Huang X.L., Cui G.H., Zhou K.Y.: "Correlation of PI3K-Akt signal pathway to apoptosis of tumor cells". Ai Zheng, 2008, 27, 331.
2. Wu C., Huang J.: "Phosphatidylinositol 3-kinase/AKT mammalian target of rapamycin pathway is essential for neuroendocrine differentiation of prostate cancer". J. Biol. Chem., 2007, 282, 3571.
3. Carnero A.: "The PKB/AKT pathway in cancer". Curr. Pharm. Des., 2010, 16, 34.
4. Wipf P., Halter R.J.: "Chemistry and biology of wortmannin". Org. Biomol. Chem., 2005, 3, 2053.
5. Hazeki O.: "Wortmannin, an inhibitor of phosphatidylinositol 3-kinase". Seikagaku, 1995, 67, 33.
6. Isbarn H., Budäus L., Pichlmeier U., Conrad S., Huland H., Friedrich M.G.: "Comparison of the effectiveness between long-term instillation of mitomycin C and short-term prophylaxis with MMC or bacille Calmette- Guérin. Study of patients with non-muscle-invasive urothelial cancer of the urinary bladder". Urologe A., 2008, 47, 608.
7. Zhang T., Cui G.B., Zhang J., Zhang F., Zhou Y.A., Jiang T. et al.: "Inhibition of PI3 kinases enhances the sensitivity of non-small cell lung cancer cells to ionizing radiation". Oncol. Rep., 2010, 24, 1683.
8. Yan J., Xu Y.H.: "Tributyrin inhibits human gastric cancer SGC-7901 cell growth by inducing apoptosis and DNA synthesis arrest". World J. Gastroenterol., 2003, 9, 660.
9. Zhang D., Fan D.: "Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges". Exp. Rev. Anticancer. Ther., 2007, 7, 1369.
10. Bartholomeusz C., Gonzalez-Angulo A.M.: "Targeting the PI3K signaling pathway in cancer therapy". Exp. Opin. Ther. Targets, 2012, 16, 121.
11. Sliva D.: "Signaling pathways responsible for cancer cell invasion as targets for cancer therapy". Curr. Cancer Drug. Targets, 2004, 4, 327.
12. Polak R., Buitenhuis M.: "The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia". Blood, 2011, 24, 1666.
13. Han Z., Hong L., Han Y., Wu K., Han S., Shen H. et al.: "PhosphoAkt mediates multidrug resistance of gastric cancer cells through regulation of P-gP, Bcl-2 and Bax". J. Exp. Clin. Cancer Res., 2007, 26, 261.
14. Lee C.H., Jeon Y.T., Kim S.H., Song Y.S.: "NF-kappaB as a potential molecular target for cancer therapy". Biofactors, 2007, 29, 19.
15. Ohta T., Ohmichi M., Hayasaka T., Mabuchi S., Saitoh M., Kawagoe J. et al.: "Inhibition of phosphatidylinositol 3-kinase increases efficacy of cisplatin in in vivo ovarian cancer models". Endocrinology, 2006, 147, 1761.
16. Poh T.W., Pervaiz S.: "LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-Akt pathway". Cancer Res., 2005, 65, 6264.